NAN vs PEB

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NAN

NANOSONICS FPO [NAN]

52MEDIUM

PEB

PACIFIC ED FPO NZX [PEB]

46LOW

Score Breakdown

NAN PEB
Technical
49
55
Catalyst
53
51
Sentiment
50
50
Fundamental
94
26
Momentum
41
67
Risk Gate
40
40

Key Metrics

NAN Metric PEB
$965.5MMarket Cap$298.0M
440KAvg Volume (20d)31K
+6.9%Short Interest+0.1%
$4.77052-Week High$0.265
$2.96052-Week Low$0.085
-0.3%Daily Change+0.0%
$3.220Reference Price$0.240
+10.1%ROE-194.7%
+9.9%Profit Margin-275.0%

Active Signals

NAN Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.7x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

PEB Signals

●Volume surging at 19.8x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (1.0 quarters)
●Revenue in sharp decline (-46%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●CANSLIM N: Near 52-week high (breakout territory)
●CANSLIM I: Institutional ownership (34%)
●Deeply negative margins (-275%)

Ask Scout AI to compare NAN and PEB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NAN vs PKY →NAN vs PTX →NAN vs RCE →NAN vs SLD →NAN vs SNT →
NAN Full Analysis → PEB Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).